Published Date: 28-Feb-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Sexually Transmitted Diseases (STD) Testing Market, published by KBV research, The Global Sexually Transmitted Diseases (STD) Testing Market size is expected to reach $119.95 billion by 2027, rising at a market growth of 4.5% CAGR during the forecast period.
The Chlamydia market dominated the Global Sexually Transmitted Diseases (STD) Testing Market by Disease Type 2020, growing at a CAGR of 3.1% during the forecast period. In women, it can cause cervicitis, and in both men and women, it can induce urethritis and proctitis. Infections with Chlamydia can cause major problems in women, including as pelvic inflammatory disease (PID), tubal factor infertility, ectopic pregnancy, and persistent pelvic pain.
The Laboratory Testing market dominated the Global Sexually Transmitted Diseases (STD) Testing Market by Location of Testing 2020, growing at a CAGR of 3.8% during the forecast period. It is owing to the fact that the most diagnostic testing is done in laboratories, which is expected to fuel STD testing demand even more. Since laboratories provide conducive environment with all the requirement chemicals and equipment, testing is more preferred in these locations for more efficiency in test results.
The Asia Pacific market dominated the Global Sexually Transmitted Diseases (STD) Testing Market by Region 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $43.26 billion by 2027. The Europe market is poised to grow at a CAGR of 4% during (2021 - 2027). Additionally, The North America market would witness a CAGR of 4.3% during (2021 - 2027).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of BioMérieux S.A., Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin Molecular LLC, Danaher Corporation, Bio-Rad Laboratories, Inc., and OraSure Technologies, Inc.
By Disease Type
By Location of Testing
Unique Offerings from KBV Research